These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 15692469)

  • 1. Long-term treatment of atopic dermatitis with pimecrolimus cream 1% in infants does not interfere with the development of protective antibodies after vaccination.
    Papp KA; Breuer K; Meurer M; Ortonne JP; Potter PC; de Prost Y; Davidson MJ; Barbier N; Goertz HP; Paul C
    J Am Acad Dermatol; 2005 Feb; 52(2):247-53. PubMed ID: 15692469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term control of atopic dermatitis with pimecrolimus cream 1% in infants and young children: a two-year study.
    Papp KA; Werfel T; Fölster-Holst R; Ortonne JP; Potter PC; de Prost Y; Davidson MJ; Barbier N; Goertz HP; Paul C
    J Am Acad Dermatol; 2005 Feb; 52(2):240-6. PubMed ID: 15692468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pimecrolimus and vaccinations].
    Schmutz JL; Barbaud A; Tréchot P
    Ann Dermatol Venereol; 2007; 134(6-7):598. PubMed ID: 17702119
    [No Abstract]   [Full Text] [Related]  

  • 4. Safety and tolerability of 1% pimecrolimus cream among infants: experience with 1133 patients treated for up to 2 years.
    Paul C; Cork M; Rossi AB; Papp KA; Barbier N; de Prost Y
    Pediatrics; 2006 Jan; 117(1):e118-28. PubMed ID: 16361223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
    Ling M; Gottlieb A; Pariser D; Caro I; Stewart D; Scott G; Abrams K
    J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained efficacy and safety of pimecrolimus cream 1% when used long-term (up to 26 weeks) to treat children with atopic dermatitis.
    Langley RG; Eichenfield LF; Lucky AW; Boguniewicz M; Barbier N; Cherill R
    Pediatr Dermatol; 2008; 25(3):301-7. PubMed ID: 18577032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of pimecrolimus cream 1% on the long-term course of pediatric atopic dermatitis.
    Papp K; Staab D; Harper J; Potter P; Puig L; Ortonne JP; Molloy S; Barbier N; Paul C;
    Int J Dermatol; 2004 Dec; 43(12):978-83. PubMed ID: 15569038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Responses to triple viral and tetanus vaccination in HIV-infected children].
    Echeverría Lecuona J; Aldamiz-Echevarría Azuara L; Cilla Eguiluz G; Pérez Trallero E
    An Esp Pediatr; 1996 Apr; 44(4):317-20. PubMed ID: 8849078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody levels to diphtheria, tetanus, and rubella in infants vaccinated while on PD: a Study of the Pediatric Peritoneal Dialysis Study Consortium.
    Neu AM; Warady BA; Furth SL; Lederman HM; Fivush BA
    Adv Perit Dial; 1997; 13():297-9. PubMed ID: 9440877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Onset of action of pimecrolimus cream 1% in the treatment of atopic eczema in infants.
    Kaufmann R; Fölster-Holst R; Höger P; Thaçi D; Löffler H; Staab D; Bräutigam M;
    J Allergy Clin Immunol; 2004 Nov; 114(5):1183-8. PubMed ID: 15536429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of nonsteroid pimecrolimus cream 1% in the treatment of atopic dermatitis in infants.
    Ho VC; Gupta A; Kaufmann R; Todd G; Vanaclocha F; Takaoka R; Fölster-Holst R; Potter P; Marshall K; Thurston M; Bush C; Cherill R
    J Pediatr; 2003 Feb; 142(2):155-62. PubMed ID: 12584537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adult patients with moderate atopic dermatitis: tacrolimus ointment versus pimecrolimus cream.
    Abramovits W; Fleischer AB; Jaracz E; Breneman D
    J Drugs Dermatol; 2008 Dec; 7(12):1153-8. PubMed ID: 19137769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pimecrolimus cream 1% in the long-term management of adult atopic dermatitis: prevention of flare progression. A randomized controlled trial.
    Gollnick H; Kaufmann R; Stough D; Heikkila H; Andriano K; Grinienko A; Jimenez P;
    Br J Dermatol; 2008 May; 158(5):1083-93. PubMed ID: 18341665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood concentrations of pimecrolimus in adult patients with atopic dermatitis following intermittent administration of pimecrolimus cream 1% (Elidel) for up to 1 year.
    Van Leent EJ; De Vries HJ; Ebelin ME; Burtin P; Scott G; Bos JD
    J Dermatolog Treat; 2007; 18(1):19-22. PubMed ID: 17365262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of atopic eczema with pimecrolimus cream 1% under daily practice conditions: results of a > 2000 patient study.
    Ring J; Abraham A; de Cuyper C; Kim K; Langeland T; Parra V; Pigatto P; Reunala T; Szczepanski R; Möhrenschlager M; Bräutigam M; Rossi AB; Meents-Kopecky E; Schneider D
    J Eur Acad Dermatol Venereol; 2008 Feb; 22(2):195-203. PubMed ID: 18211413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of pimecrolimus cream 1% for the treatment of mild to moderate atopic dermatitis.
    Hebert AA
    Clin Ther; 2006 Dec; 28(12):1972-82. PubMed ID: 17296454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical management of atopic eczema with pimecrolimus cream 1% (Elidel) in paediatric patients.
    Eichenfield LF; Thaci D; de Prost Y; Puig L; Paul C
    Dermatology; 2007; 215 Suppl 1():3-17. PubMed ID: 18174689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term safety and tolerability of pimecrolimus cream 1% and topical corticosteroids in adults with moderate to severe atopic dermatitis.
    Luger TA; Lahfa M; Fölster-Holst R; Gulliver WP; Allen R; Molloy S; Barbier N; Paul C; Bos JD
    J Dermatolog Treat; 2004 Jun; 15(3):169-78. PubMed ID: 15204150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of early intervention with pimecrolimus cream 1% combined with corticosteroids for major flares in infants and children with atopic dermatitis.
    Siegfried E; Korman N; Molina C; Kianifard F; Abrams K
    J Dermatolog Treat; 2006; 17(3):143-50. PubMed ID: 16854753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pneumococcal seroconversion after vaccination for children with atopic dermatitis treated with tacrolimus ointment.
    Stiehm ER; Roberts RL; Kaplan MS; Corren J; Jaracz E; Rico MJ
    J Am Acad Dermatol; 2005 Aug; 53(2 Suppl 2):S206-13. PubMed ID: 16021176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.